{"id":65674,"date":"2026-05-19T20:24:24","date_gmt":"2026-05-19T12:24:24","guid":{"rendered":"https:\/\/flcube.com\/?p=65674"},"modified":"2026-05-19T20:24:25","modified_gmt":"2026-05-19T12:24:25","slug":"china-tightens-medical-insurance-personal-account-oversight-with-mandatory-white-list-for-retail-pharmacy-purchases","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=65674","title":{"rendered":"China Tightens Medical Insurance Personal Account Oversight with Mandatory &#8220;White List&#8221; for Retail Pharmacy Purchases"},"content":{"rendered":"\n<p>China&#8217;s <strong>National Healthcare Security Administration (NHSA)<\/strong> and <strong>Ministry of Finance<\/strong> jointly issued a <strong>comprehensive notice<\/strong> strengthening supervision of <strong>personal medical account usage<\/strong> under the <strong>basic medical insurance (BMI) scheme for employees<\/strong> at <strong>designated retail pharmacies<\/strong>. The directive mandates provincial authorities to implement a <strong>&#8220;white list&#8221; system<\/strong> by <strong>September 2026<\/strong>, explicitly excluding health supplements and daily necessities while requiring strict oversight of eligible medical products.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-regulatory-framework-amp-implementation-timeline\">Regulatory Framework &amp; Implementation Timeline<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Requirement<\/th><th>Deadline<\/th><th>Scope<\/th><\/tr><\/thead><tbody><tr><td><strong>White List Implementation<\/strong><\/td><td>End of September 2026<\/td><td>Provincial-level healthcare security authorities<\/td><\/tr><tr><td><strong>Eligible Items<\/strong><\/td><td>Immediate effect upon white list publication<\/td><td>Drugs, medical devices, medical consumables only<\/td><\/tr><tr><td><strong>Excluded Items<\/strong><\/td><td>Immediate prohibition<\/td><td>Health supplements, daily necessities<\/td><\/tr><tr><td><strong>Compliance Monitoring<\/strong><\/td><td>Ongoing<\/td><td>Enhanced fund oversight and pharmacy management<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-white-list-eligibility-criteria\">White List Eligibility Criteria<\/h2>\n\n\n\n<p>Items qualifying for inclusion on provincial white lists must meet <strong>strict regulatory and clinical standards<\/strong>:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Regulatory Approval<\/strong>: Must be <strong>formally approved or registered<\/strong> by drug regulatory authorities for retail pharmacy sale<\/li>\n\n\n\n<li><strong>Medical Necessity<\/strong>: Must be <strong>closely related to treatment<\/strong> with <strong>strong medical attributes<\/strong><\/li>\n\n\n\n<li><strong>Pricing Standards<\/strong>: Must demonstrate <strong>reasonable pricing<\/strong> aligned with therapeutic value<\/li>\n\n\n\n<li><strong>Product Categories<\/strong>: Limited to <strong>drugs, medical devices, and medical consumables<\/strong> only<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-prohibited-practices-amp-enforcement-measures\">Prohibited Practices &amp; Enforcement Measures<\/h2>\n\n\n\n<p>The notice establishes <strong>zero-tolerance policies<\/strong> for retail pharmacy misconduct:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Consumer Inducement<\/strong>: Strictly prohibited from <strong>inducing consumer spending<\/strong> through promotional tactics<\/li>\n\n\n\n<li><strong>Price Inflation<\/strong>: <strong>Inflating prices<\/strong> to maximize personal account utilization is forbidden<\/li>\n\n\n\n<li><strong>Agreement-Based Management<\/strong>: Enhanced contractual oversight of designated retail pharmacies<\/li>\n\n\n\n<li><strong>Fund Protection<\/strong>: <strong>Intensified oversight<\/strong> of healthcare security funds to prevent misuse<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-impact-amp-industry-implications\">Market Impact &amp; Industry Implications<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Retail Pharmacy Revenue<\/strong>: Estimated <strong>15-20% revenue impact<\/strong> for pharmacies heavily reliant on personal account purchases of excluded items<\/li>\n\n\n\n<li><strong>Pharmaceutical Manufacturers<\/strong>: Shift toward <strong>medically necessary products<\/strong> with clear therapeutic indications<\/li>\n\n\n\n<li><strong>Health Supplement Sector<\/strong>: <strong>Complete exclusion<\/strong> from insurance reimbursement eliminates significant sales channel<\/li>\n\n\n\n<li><strong>Consumer Behavior<\/strong>: Patients must now pay <strong>out-of-pocket<\/strong> for non-medical items previously covered through personal accounts<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-rationale-amp-policy-objectives\">Strategic Rationale &amp; Policy Objectives<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Basic Protection Principle<\/strong>: Reinforces the <strong>&#8220;basic protection&#8221; function<\/strong> of employee medical insurance, preventing scope creep into lifestyle products<\/li>\n\n\n\n<li><strong>Fund Sustainability<\/strong>: Protects <strong>healthcare security fund integrity<\/strong> amid rising medical costs and aging population pressures<\/li>\n\n\n\n<li><strong>Rational Utilization<\/strong>: Promotes <strong>reasonable, prudent, flexible, and well-regulated<\/strong> approach to personal account management<\/li>\n\n\n\n<li><strong>Healthcare Quality<\/strong>: Ensures insurance funds support <strong>evidence-based medical care<\/strong> rather than discretionary purchases<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-implementation-challenges-amp-opportunities\">Implementation Challenges &amp; Opportunities<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Provincial Coordination<\/strong>: Variations in white list composition across provinces may create market fragmentation<\/li>\n\n\n\n<li><strong>Digital Infrastructure<\/strong>: Requires robust <strong>medical code management systems<\/strong> for real-time eligibility verification<\/li>\n\n\n\n<li><strong>Compliance Costs<\/strong>: Pharmacies face increased administrative burden for product categorization and transaction monitoring<\/li>\n\n\n\n<li><strong>Innovation Incentives<\/strong>: Encourages development of <strong>high-value medical products<\/strong> that meet stringent white list criteria<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-broader-healthcare-reform-context\">Broader Healthcare Reform Context<\/h2>\n\n\n\n<p>This directive aligns with China&#8217;s comprehensive healthcare reform agenda:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Insurance System Integrity<\/strong>: Part of broader efforts to strengthen basic medical insurance sustainability<\/li>\n\n\n\n<li><strong>Value-Based Care<\/strong>: Supports transition toward outcomes-focused healthcare delivery<\/li>\n\n\n\n<li><strong>Regulatory Harmonization<\/strong>: Complements ongoing efforts to standardize medical product classification and pricing<\/li>\n\n\n\n<li><strong>Anti-Corruption Measures<\/strong>: Addresses historical concerns about insurance fund misuse in retail pharmacy settings<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward-Looking Statements<\/strong><br>This brief contains forward-looking statements regarding regulatory implementation, market impacts, and policy outcomes. Actual results may differ due to risks including provincial implementation variations, industry adaptation challenges, and evolving regulatory interpretations.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>China&#8217;s National Healthcare Security Administration (NHSA) and Ministry of Finance jointly issued a comprehensive notice&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[4],"tags":[67,78],"class_list":["post-65674","post","type-post","status-publish","format-standard","hentry","category-policy-regulatory","tag-nhsa-prev-smia","tag-otc-retail"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>China Tightens Medical Insurance Personal Account Oversight with Mandatory &quot;White List&quot; for Retail Pharmacy Purchases - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China&#039;s National Healthcare Security Administration (NHSA) and Ministry of Finance jointly issued a comprehensive notice strengthening supervision of personal medical account usage under the basic medical insurance (BMI) scheme for employees at designated retail pharmacies. The directive mandates provincial authorities to implement a &quot;white list&quot; system by September 2026, explicitly excluding health supplements and daily necessities while requiring strict oversight of eligible medical products.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=65674\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"China Tightens Medical Insurance Personal Account Oversight with Mandatory &quot;White List&quot; for Retail Pharmacy Purchases\" \/>\n<meta property=\"og:description\" content=\"China&#039;s National Healthcare Security Administration (NHSA) and Ministry of Finance jointly issued a comprehensive notice strengthening supervision of personal medical account usage under the basic medical insurance (BMI) scheme for employees at designated retail pharmacies. The directive mandates provincial authorities to implement a &quot;white list&quot; system by September 2026, explicitly excluding health supplements and daily necessities while requiring strict oversight of eligible medical products.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=65674\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-19T12:24:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-19T12:24:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65674#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65674\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"China Tightens Medical Insurance Personal Account Oversight with Mandatory &#8220;White List&#8221; for Retail Pharmacy Purchases\",\"datePublished\":\"2026-05-19T12:24:24+00:00\",\"dateModified\":\"2026-05-19T12:24:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65674\"},\"wordCount\":530,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"NHSA (prev. SMIA)\",\"OTC \\\/ retail\"],\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=65674#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65674\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=65674\",\"name\":\"China Tightens Medical Insurance Personal Account Oversight with Mandatory \\\"White List\\\" for Retail Pharmacy Purchases - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-05-19T12:24:24+00:00\",\"dateModified\":\"2026-05-19T12:24:25+00:00\",\"description\":\"China's National Healthcare Security Administration (NHSA) and Ministry of Finance jointly issued a comprehensive notice strengthening supervision of personal medical account usage under the basic medical insurance (BMI) scheme for employees at designated retail pharmacies. The directive mandates provincial authorities to implement a \\\"white list\\\" system by September 2026, explicitly excluding health supplements and daily necessities while requiring strict oversight of eligible medical products.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65674#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=65674\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=65674#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"China Tightens Medical Insurance Personal Account Oversight with Mandatory &#8220;White List&#8221; for Retail Pharmacy Purchases\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"China Tightens Medical Insurance Personal Account Oversight with Mandatory \"White List\" for Retail Pharmacy Purchases - Insight, China&#039;s Pharmaceutical Industry","description":"China's National Healthcare Security Administration (NHSA) and Ministry of Finance jointly issued a comprehensive notice strengthening supervision of personal medical account usage under the basic medical insurance (BMI) scheme for employees at designated retail pharmacies. The directive mandates provincial authorities to implement a \"white list\" system by September 2026, explicitly excluding health supplements and daily necessities while requiring strict oversight of eligible medical products.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=65674","og_locale":"en_US","og_type":"article","og_title":"China Tightens Medical Insurance Personal Account Oversight with Mandatory \"White List\" for Retail Pharmacy Purchases","og_description":"China's National Healthcare Security Administration (NHSA) and Ministry of Finance jointly issued a comprehensive notice strengthening supervision of personal medical account usage under the basic medical insurance (BMI) scheme for employees at designated retail pharmacies. The directive mandates provincial authorities to implement a \"white list\" system by September 2026, explicitly excluding health supplements and daily necessities while requiring strict oversight of eligible medical products.","og_url":"https:\/\/flcube.com\/?p=65674","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-05-19T12:24:24+00:00","article_modified_time":"2026-05-19T12:24:25+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=65674#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=65674"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"China Tightens Medical Insurance Personal Account Oversight with Mandatory &#8220;White List&#8221; for Retail Pharmacy Purchases","datePublished":"2026-05-19T12:24:24+00:00","dateModified":"2026-05-19T12:24:25+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=65674"},"wordCount":530,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["NHSA (prev. SMIA)","OTC \/ retail"],"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=65674#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=65674","url":"https:\/\/flcube.com\/?p=65674","name":"China Tightens Medical Insurance Personal Account Oversight with Mandatory \"White List\" for Retail Pharmacy Purchases - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-05-19T12:24:24+00:00","dateModified":"2026-05-19T12:24:25+00:00","description":"China's National Healthcare Security Administration (NHSA) and Ministry of Finance jointly issued a comprehensive notice strengthening supervision of personal medical account usage under the basic medical insurance (BMI) scheme for employees at designated retail pharmacies. The directive mandates provincial authorities to implement a \"white list\" system by September 2026, explicitly excluding health supplements and daily necessities while requiring strict oversight of eligible medical products.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=65674#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=65674"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=65674#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"China Tightens Medical Insurance Personal Account Oversight with Mandatory &#8220;White List&#8221; for Retail Pharmacy Purchases"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/65674","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=65674"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/65674\/revisions"}],"predecessor-version":[{"id":65675,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/65674\/revisions\/65675"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=65674"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=65674"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=65674"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}